breast cancer patients
Conditions
Interventions
Yokukansan group take 2.5 g of yokukansan before asleep on the previous day and 2hr before the surgery on the operation day.
Control group take nothing.
Sponsors
Niigata university Guraduate school of medical and dental sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients who undergo total breast excision and sentinel lymph node biopsy, or breast partial resection and sentinel lymph node biopsy
Exclusion criteria
Exclusion criteria: patients who -disagree to participate in this study -ASA-physical status =/>4 -Body Mass Index=/>30kg/m2 -has difficulty for communication (eg. patient suffered from dementia, has mental retardation, can not understand Japanese) -has allergy for the drugs that will use in this study -is suffering from pain -is received anxiolytic or antipsychotic medication. -is received analgesics or opioid medication -whom the examiner assume inadequate to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| subjective evaluation items: HADS( Hospital anxiety and depression scale) objective evaluation items: salivaly amylase activity | — |
Secondary
| Measure | Time frame |
|---|---|
| STAI(State Trait Anxiety Inventory) QoR (quality of recovery) score VAS score of pain | — |
Countries
Japan
Contacts
Public ContactMoegi Tanaka
Niigata university Guraduate school of medical and dental sciences division of Anesthesiology
Outcome results
None listed